Are you a UF student registering for Fall 2024 courses? Consider enrolling in ‘Social Stratification & Health’, which is taught by Dr. Ashby Walker. This course examines the extent, causes, and consequences of social and economic inequality in the U.S. and its impact on health. To enroll, email Brittany Crown at bweintraut@phhp.ufl.edu ..read more

Brynlee Clevenger takes on T1D with a huge heart for helping others For 10-year-old Brynlee Clevenger, it was the possibility of helping other kids with type 1 diabetes (T1D) that prompted her to join a clinical trial ..read more

By Jill Pease A new University of Florida College of Public Health and Health Professions study seeks to better characterize populations living with insulin-requiring diabetes, including Type 1 diabetes, seen at a Federally Qualified Health Center, or FQHC, and to identify challenges faced by primary care physicians delivering diabetes care to underserved communities ..read more

Join the UF Diabetes Institute for a seminar on Monday, June 17th from 12:00-1:00 p.m. at Communicore C1-004 or online via Zoom. Ake Lernmark, Ph.D, is a sr. professor at Lund University in Sweden. The seminar title is ““Genetic and environmental aetiology of type 1 diabetes ..read more

Dr. Desmond Schatz’s recognition as the recipient of the 2024 David A. Paulus Award for Clinical Excellence is a testament to his outstanding contributions to the field of pediatrics and diabetes care. As a Professor of Pediatrics and Pediatric Medical Director of the UF Diabetes Institute, Dr. Schatz embodies the ideals of clinical excellence espoused by Dr. David Paulus. His dedication to patient care is exemplary, as he engages at every level to ensure the best possible outcomes for his patients. Dr. Schatz’s commitment to teamwork fosters collaborative efforts in healthcare delivery, enha ..read more

Join the UF Diabetes Institute for a seminar on Wednesday, May 22th from 12:00-1:00 p.m. at Communicore C1-003 or online via Zoom. Mark S. Anderson, MD, Ph.D, is an Endowed Chair of Research and Director of the Diabetes Center at the University of California – San Francisco. The seminar title is “Using outliers to unravel the pathogenesis of autoimmunity”, This event is free and open to the public. Attendees must register for the webinar by 11:00 a.m ..read more

Read our 2023 Year in Review to see our accomplishments over the past year as a global leader in diabetes research, patient care, and education ..read more

A photograph captured by Laura Jacobsen, MD, during the Florida Diabetes Camp has been featured on the cover of the February edition of the Diabetes Care journal. Click here to read the article and discover more about the artist, a pediatric endocrinologist and UFDI scientist ..read more

Register Now for the Event “Using Artifical Intelligence to Address Inequities in Diabetes at the University of Florida ..read more

Amber Van Den Heuvel received low-dose anti-thymocyte globulin (ATG) in 2015 as a participant in a TrialNet clinical study for people newly diagnosed with type 1 diabetes (T1D). Five years later, she still had beta cell function. Today, at age 26, Amber is encouraging people at high risk for T1D to consider participating in a TrialNet prevention study using the same therapy ..read more